Article

Epilepsy surgery trends in the United States, 1990-2008

UCSF Epilepsy Center, University of California, San Francisco, CA, USA.
Neurology (Impact Factor: 8.3). 03/2012; 78(16):1200-6. DOI: 10.1212/WNL.0b013e318250d7ea
Source: PubMed

ABSTRACT To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its efficacy and subsequent practice guidelines recommending early surgical evaluation.
We performed a population-based cohort study with time trends of patients admitted to US hospitals for medically refractory focal epilepsy between 1990 and 2008 who did or did not undergo lobectomy, as reported in the Nationwide Inpatient Sample.
Weighted data revealed 112,026 hospitalizations for medically refractory focal epilepsy and 6,653 resective surgeries (lobectomies and partial lobectomies) from 1990 to 2008. A trend of increasing hospitalizations over time was not accompanied by an increase in surgeries, producing an overall trend of decreasing surgery rates (F = 13.6, p < 0.01). Factors associated with this trend included a decrease in epilepsy hospitalizations at the highest-volume epilepsy centers, and increased hospitalizations to lower-volume hospitals that were found to be less likely to perform surgery. White patients were more likely to have surgery than racial minorities (relative risk [RR], 1.13; 95% confidence interval [CI], 1.10-1.17), and privately insured individuals were more likely to receive lobectomy than those with Medicaid or Medicare (RR, 1.28; 95% CI, 1.25-1.30).
Despite Class I evidence and subsequent practice guidelines, the utilization of lobectomy has not increased from 1990 to 2008. Surgery continues to be heavily underutilized as a treatment for epilepsy, with significant disparities by race and insurance coverage. Patients who are medically refractory after failing 2 antiepileptic medications should be referred to a comprehensive epilepsy center for surgical evaluation.

1 Follower
 · 
122 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Clear evidence supports the benefits of surgery over medical therapy for patients with refractory focal epilepsy. Surgical procedures meet the needs of fewer than 2% of those eligible. Referral to a tertiary epilepsy center early in the course of disease is recommended; however, patients live with disabling and life-threatening seizures for an average of 22years before considering surgical treatment. Reasons for this treatment gap are unclear. A critical analysis of the literature addressing perceptions of surgical treatment for epilepsy is placed in the context of a brief history and current treatment guidelines. Common conceptual themes shaping perceptions of epilepsy surgery are identified. Data sources used for this study were PubMed-MEDLINE and PsycINFO from 2003 to December 2013; hand searches of reference lists. Nine papers that addressed patient perceptions of surgery for epilepsy and three papers addressing physician attitudes were reviewed. Treatment misperceptions held by both patients and physicians lead to undertreatment and serious health consequences. Fear of surgery, ignorance of treatment options, and tolerance of symptoms emerge as a triad of responses central to weighing treatment risks and benefits and, ultimately, to influencing treatment decision-making. Our novel explanatory framework serves to illustrate and explain relationships among contributory factors. Comparisons across studies are limited by the heterogeneity of study populations and by the fact that no instrument has been developed to consistently measure disability in refractory focal epilepsy. Exploring the components of decision-making for the management of refractory focal epilepsy from the patient's perspective presents a new angle on a serious contemporary challenge in epilepsy care and may lead to explanation as to why there is reluctance to embrace a safe and effective treatment. Copyright © 2014 Elsevier Inc. All rights reserved.
    Epilepsy & Behavior 02/2015; 44C:171-178. DOI:10.1016/j.yebeh.2014.12.027 · 2.06 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Epilepsy surgery (ES) not only remains one of the most underutilized of all accepted medical interventions, but there has also been a decrease in referrals for ES in recent years in high-income countries. We undertook this study to determine the temporal trends of ES and its current state in India. We asked the directors of epilepsy centers across India to complete an online questionnaire about the number and type of ES procedures carried out from 1995 or commencement of the program till December 2012. During the 18-year period, a total of 4252 ES have been undertaken. On an average, 420 ES were being carried out each year in India. Three-fourths of resective surgeries involved the temporal lobe. Although majority of patients were selected for ES by noninvasive strategies, 13 centers had performed long-term invasive EEG monitoring to select complex cases. In between 1995-2000 and 2007-2012, the number of ES carried out in India registered an increase by three-fold. A steadily increasing number of eligible patients with drug-resistant epilepsy in India are undergoing ES in recent years. This temporal trend of ES in India is in contrast to the recent experience of high-income countries. Copyright © 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
    Seizure 01/2015; 26. DOI:10.1016/j.seizure.2015.01.005 · 2.06 Impact Factor
  • The Lancet Neurology 01/2015; 14(3). DOI:10.1016/S1474-4422(15)70011-6 · 21.82 Impact Factor

Full-text (2 Sources)

Download
8 Downloads
Available from
Sep 24, 2014